What is intranasal drug delivery? A complete guide
How nasal sprays deliver drugs through the nasal mucosa — formats, benefits and the manufacturing considerations that matter.
Press coverage, certifications, recognitions and company milestones — from the Piramal Alternatives investment to new accreditations and global partnerships.
Expert perspectives on nasal spray drug delivery, injectable manufacturing, nutraceutical formulation, regulatory affairs and global export markets — alongside the latest Biodeal company news.
How nasal sprays deliver drugs through the nasal mucosa — formats, benefits and the manufacturing considerations that matter.
A practical comparison of the two dominant nasal-spray formats, and how to choose the right one for your molecule.
Inside the Grade A/B clean rooms, aseptic filling and controls behind reliable sterile injectable production.
Why freeze-drying matters for stability, and what it means for your injectable development timeline.
The credentials, capabilities and quality systems that separate a reliable CDMO partner from the rest.
A landmark institutional investment to scale injectable capacity, strengthen our nasal spray leadership and expand export infrastructure.
How our formulation, device and dossier teams take a molecule from concept to regulated-market launch.
How WHO-GMP and PIC/S certification open regulated and semi-regulated markets across six global regions.
A key regulated-market clearance that extends Biodeal's reach into North America and validates our quality systems.
Recognition of our nutraceutical contract-manufacturing depth across capsules, gummies, powders and effervescents.
For press enquiries, interviews, company facts or media assets, reach our communications team — we typically respond within 48 business hours.